Table 6 |
||||
|
Univariate survival analysis of patients' renal prognosis with lupus nephritis |
||||
|
HR |
95% confidence interval |
P-value |
||
|
|
||||
|
Age |
0.947 |
0.896 |
1.002 |
0.057 |
|
Sex |
0.252 |
0.089 |
0.717 |
0.010 |
|
Proteinuria |
1.109 |
1.009 |
1.220 |
0.032 |
|
Serum creatinine value |
1.003 |
1.002 |
1.005 |
<0.001 |
|
ANA |
0.049 |
0.000 |
0.000 |
0.912 |
|
Anti-ds-DNA antibody |
0.970 |
0.353 |
2.664 |
0.953 |
|
SLEDAI |
0.961 |
0.885 |
1.043 |
0.344 |
|
Activity indices (AI) score |
1.220 |
1.080 |
1.378 |
0.001 |
|
Chronicity indices (CIs) score |
1.428 |
1.191 |
1.713 |
<0.001 |
|
Renal TMA |
0.275 |
0.105 |
0.721 |
0.009 |
|
Anti-cardiolipin antibody |
23.596 |
0.012 |
45,236 |
0.412 |
|
anti-β2GP-1 antibody |
25.022 |
0.001 |
647,548 |
0.535 |
|
ADAMTS13 activity |
1.542 |
0.161 |
14.764 |
0.707 |
|
Complement factor H |
0.998 |
0.996 |
1.001 |
0.247 |
|
Vascular C4d deposition |
0.815 |
0.320 |
2.078 |
0.669 |
|
|
||||
|
Song et al. Arthritis Research & Therapy 2013 15:R12 doi:10.1186/ar4142 |
||||